Molecular Formula | C8H14N2O5S2 |
Molar Mass | 282.33716 |
Density | 1.226±0.06 g/cm3(Predicted) |
Melting Point | 147-149 °C(Solv: ethanol (64-17-5)) |
Boling Point | 441.0±40.0 °C(Predicted) |
Water Solubility | H2O: ≥20mg/mL |
Appearance | 形态 lyophilized powder 颜色 white to off-white |
pKa | 9.21±0.10(Predicted) |
Storage Condition | 2-8°C |
Use | N-acetylcysteine amide is an antioxidant that can penetrate cell membrane, has anti-inflammatory activity, and can regulate NF-κB activation, HIF-1α and ROS. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
WGK Germany | 3 |
Target | Value |
NF-κ B () |
|
HIF-1α () |
|
ROS () |
In vitro studies
N-Acetylcysteine amide shows no obvious effect on the viability of H9c2 cells treated with doxorubicin (DOX) at < 1 mM, but causes significant cytotoxicity at 10-20 mM. N-Acetylcysteine amide (750 μM) reduces the ROS levle and lipid peroxidation induced by DOX, and restores GSH/GSSG ratio and activities of antioxidant enzymes, such as catalase (CAT), gluthathione peroxidase (GPx), gluthathione reductase (GR). N-Acetylcysteine amide (1 mM) protects the human brain microvascular endothelial (HBMVEC) from methamphetamine (METH)- induced cell death.
In vivo studies
N-Acetylcysteine amide has increased CNS bioavailability. N-Acetylcysteine amide (150 mg/kg, I .p.) improves cortical sparing and functional outcome, reduces oxidative stress, improves mitochondrial bioenergetics, and maintains mitochondrial glutathione content following traumatic brain injury (TBI) in rats.